Striae of pregnancy
https://doi.org/10.21518/2079-701X-2021-13-151-155
Abstract
Striae may form on the skin due to a number of factors: rapid weight gain, muscle hypertrophy, endocrinopathies, breast enlargement, as a side effect of long-term topical use of strong corticosteroids. However, in some rare circumstances, striae can develop as a complication due to the use of tissue expanders. This cosmetic defect develops most often on the skin of the thighs, abdomen, mammary glands in women and the shoulders in men. Striae of pregnancy are a common cosmetic skin defect. The development of striae is associated with stretching and rupture of connective tissue in susceptible individuals against the background of influence of genetic and hormonal factors. The appearance of striae gravidarum does not have a significant effect on the health of patients, however, a cosmetic defect caused by the appearance of striae can generate psychoemotional (psychoemotional) stress and lead to a decrease in quality of life. The striae development occurs in certain stages. The initial period of striae development – red (immature) striae – is characterized by the absence of changes in the epidermis and signs of inflammation in the dermis. The appearance of white (mature) striae is accompanied by the architectural distortion of elastic fibre net and changes in the viscoelastic properties of the affected skin, which becomes much less elastic. The correction of striae requires topical treatment that help moisturize and soften the skin, stimulate the processes of collagen production, as well as physiotherapy techniques. However, many of them have contraindications for use during pregnancy. The article discusses the issues of the use of cosmetic products that can be used during pregnancy.
About the Author
E. V. Dvoriankova
Center for Theoretical Problems of Physico-Chemical Pharmacology of the RAS
Russian Federation
Russian Federation
Evgeniya V. Dvoriankova, Dr. Sci. (Med.), Leading Researcher
30 , Srednyaya Kalitnikovskaya St., Moscow, 109029, Russia
References
1. Picard D., Sellier S., Houivet E., Marpeau L., Fournet P., Thobois B. Incidence and risk factors for striae gravidarum. J Am Acad Dermatol. 2015;73(4):699–700. https://doi.org/10.1016/j.jaad.2015.06.037.
2. Chang A.L., Agredano Y.Z., Kimball A.B. Risk factors associated with striae gravidarum. J Am Acad Dermatol. 2004;51(6):881–885. https://doi.org/10.1016/j.jaad.2004.05.030.
3. Owsei T. Gynecology. Baltimore: John Hopkins University Press; 1991. Available at: https://books.google.ru/books?hl=ru&lr=&id=YsKWfh31gxwC&oi=fnd&pg=PR9&dq=Owsei.
4. Farahnik B., Park K., Kroumpouzos G., Murase J. Striae gravidarum: Risk factors, prevention, and management. Int J Womens Dermatol. 2017;3(2):77–85. https://doi.org/10.1016/j.ijwd.2016.11.001.
5. Atwal G.S., Manku L.K., Griffiths C.E., Polson D.W. Striae gravidarum in primiparae. Br J Dermatol.2006;155(5):965–969. https://doi.org/10.1111/j.1365-2133.2006.07427.x.
6. Chang A.L., Agredano Y.Z., Kimball A.B. Risk factors associated with striae gravidarum. J Am Acad Dermatol. 2004;51(6):881–885. https://doi.org/10.1016/j.jaad.2004.05.030.
7. Cordeiro R.C., Zecchin K.G., de Moraes A.M. Expression of estrogen, androgen, and glucocorticoid receptors in recent striae distensae. Int J Dermatol. 2010;49(1):30–32. https://doi.org/10.1111/j.1365-4632.2008.04005.x.
8. Wang F., Calderone K., Smith N.R., Do T.T., Helfrich Y.R., Johnson T.R. et al. Marked disruption and aberrant regulation of elastic fibres in early striae gravidarum. Br J Dermatol. 2015;173(6):1420–1430. https://doi.org/10.1111/bjd.14027.
9. Bertin C., Lopes-Da Cunha A., Nkengne A., Roure R., Stamatas G.N. Striae distensae are characterized by distinct microstructural features as measured by non-invasive methods in vivo. Skin Res Technol. 2014;20(1):81–86. https://doi.org/10.1111/srt.12088.
10. Stamatas G.N., Lopes-DaCunha A., Nkengne A., Bertin C. Biophysical properties of Striae Distensae evaluated in vivo using non-invasive assays. Skin Res Technol. 2015;21(2):254—258. https://doi.org/10.1111/srt.12186.
11. Wollina U., Goldman A. Management of stretch marks (with a focus on striae rubrae). J Cutan Aesthet Surg. 2017;10(3):124–129. https://doi.org/10.4103/JCAS.JCAS_118_17.
12. Kordi M., Fakari F.R., Mazloum S.R., Layegh P. Quality of Life Evaluation in Iranian Postpartum Women With and Without Striae Gravidarum. Iran J Psychiatry Behav Sci. 2016;10(2):e3993. https://doi.org/10.17795/ijpbs-3993.
13. Yamaguchi K., Suganuma N., Ohashi K. Quality of life evaluation in Japanese pregnant women with striae gravidarum: a cross-sectional study. BMC Res Notes. 2012;5:450. https://doi.org/10.1186/1756-0500-5-450.
14. García Hernández J.Á., Madera González D., Padilla Castillo M., Figueras Falcón T. Use of a specific anti-stretch mark cream for preventing or reducing the severity of striae gravidarum. Randomized, double-blind, controlled trial. Int J Cosmet Sci. 2013;35(3):233–237. https://doi.org/10.1111/ics.12029.
15. Hexsel D., Soirefmann M., Porto M.D., Schilling-Souza J., Siega C., Dal’Forno T. Superficial dermabrasion versus topical tretinoin on early striae distensae: a randomized, pilot study. Dermatol Surg. 2014;40(5):537–544. https://doi.org/10.1111/dsu.12460.
16. Ibrahim Z.A., El-Tatawy R.A., El-Samongy M.A., Ali D.A. Comparison between the efficacy and safety of platelet-rich plasma vs. microdermabrasion in the treatment of striae distensae: clinical and histopathological study. J Cosmet Dermatol. 2015;14(4):336–346. https://doi.org/10.1111/jocd.12160.
17. Dover J.S., Rothaus K., Gold M.H. Evaluation of safety and patient subjective efficacy of using radiofrequency and pulsed magnetic fields for the treat ment of striae (stretch marks). J Clin Aesthet Dermatol. 2014;7(9):30–33. Available at: https://pubmed.ncbi.nlm.nih.gov/25276274.
18. Park K.Y., Kim H.K., Kim S.E., Kim B.J., Kim M.N. Treatment of striae distensae using needling therapy: a pilot study. Dermatol Surg. 2012;38(11):1823–1828. https://doi.org/10.1111/j.1524-4725.2012.02552.x.
19. McDaniel D.H., Ash K., Zukowski M. Тreatment of stretch marks with the 585-nm flashlamp-pumped pulsed dye laser. Dermatol Surg. 1996;22(4):332–337. https://doi.org/10.1111/j.1524-4725.1996.tb00326.x.
20. Elias P.M., Brown B.E., Ziboh V.A. The permeability barrier in essential fatty acid deficiency: Evidence for a direct role for linoleic acid in barrier func tion. J Invest Dermatol. 1980;74(4):230–233. Available at: https://www.jidonline.org/article/S0022-202X(15)45763-X/pdf.
21. Ivanov D.S., . Lević J.D., Sredanović S.A. Fatty acid composition of various soybean products. Food Feed Res. 2010;37(2):65–70. Available at: https://agris.fao.org/agris-search/search.do?recordID=RS2011002382.
22. Hollinger J.C., Angra K., Halder R.M. Are natural ingredients effective in the management of hyperpigmentation? A systematic review. J Clin Aesthet Dermatol. 2018;11(2):28–37. Available at: https://pubmed.ncbi.nlm.nih.gov/29552273.
23. Eichenfield L.F., McCollum A., Msika P. The benefits of sunflower oleodis tillate (SOD) in pediatric dermatology. Pediatr Dermatol. 2009;26(6):669–675. https://doi.org/10.1111/j.1525-1470.2009.01042.x.
24. Saengsorn K., Jimtaisong A. Determination of hydrophilic–lipophilic balance value and emulsion properties of sacha inchi oil. Asian Pac J Trop Biomed. 2017;7(12):1092–1096. https://doi.org/10.1016/j.apjtb.2017.10.011.
25. Lin T.-K., Zhong L., Santiago J.L. Antiinflammatory and skin barrier repair effects of topical application of some plant oils. Int J Mol. 2018;19(1):70. https://doi.org/10.3390/ijms19010070.
26. Parker J., Schellenberger A.N., Roe A.L., Oketch-Rabah H., Calderón A.I. Therapeutic perspectives on chia seed and its oil: A review. Planta Med. 2018;84(09/10):606–612. https://doi.org/10.1055/a-0586-4711.
27. Mistry N. Guidelines for formulating antipollution products. Cosmetics. 2017;4(4):57. https://doi.org/10.3390/cosmetics4040057.
28. Ponomareva S.Yu., Vandyshev V.V., Suslina S.N. Pomegranate oil as a source of phytoestrogens. Elektronnyy sbornik nauchnykh trudov “Zdorov'ye i obrazo vaniye v XXI veke” = On line Scientific & Educational Bulletin “Health and Education Millennium”. 2006;8(12):614.(In Russ.) Available at: https://www.elibrary.ru/item.asp?id=23776217.
29. Novruzov E.N., Zeynalova A.M. Biological activity and therapeutic effect of pomegranete seed oil. Rastitelnyye resursy = Plant Resources. 2019;55(2):186–194. (In Russ.) https://doi.org/10.1134/S0033994619020080.
Review
For citations:
Dvoriankova EV. Striae of pregnancy. Meditsinskiy sovet = Medical Council. 2021;(13):151-155. (In Russ.) https://doi.org/10.21518/2079-701X-2021-13-151-155
Views:
503
Email this article 